Showing results (351-360 of 423) with videos related to
Sort By:
Pageof 43
Biorxiv : the Preprint Server for Biology|January 7, 2025
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma ModelSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma modelsYingchao Zhao, Pinan Liu, Na Zhang, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 10, 2019
Factors Influencing Access to Cochlear Implantation in Deaf and Hard-of-Hearing Children in Southern CaliforniaOmid Moshtaghi, Edward C Kuan, Hossein Mahboubi, et al.The Laryngoscope|December 5, 2019
Quantifying tinnitus suppression in cochlear implantation using tinnitus interval-limited trackingJonathan R Mallen, Jerlon Chiu, Hillary Marquis, et al.Journal of Neurochemistry|November 1, 2011
Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neuronsJulia H Kim, Daniel S Roberts, Yinghui Hu, et al.Annals of the Rheumatic Diseases|July 31, 2013
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER studyJosef S Smolen, Jonathan Kay, Eric L Matteson, et al.Plos One|May 24, 2021
Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative studyKate L Lapane, Divya Shridharmurthy, Sara Khan, et al.Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.Pageof 43